Literature DB >> 12665510

Activin a signaling induces Smad2, but not Smad3, requiring protein kinase a activity in granulosa cells from the avian ovary.

Bernhard Schmierer1, Michael K Schuster, Alena Shkumatava, Karl Kuchler.   

Abstract

Activin A signaling is an important regulator of ovarian granulosa cell function. The cytosolic signal transducer Smad2 is most highly expressed in chicken granulosa cells (cGC) of preovulatory follicles. Moreover, Smad2 shows predominant nuclear localization in freshly isolated cGC, indicating active Smad signaling in vivo. Primary cGC cultured in vitro require activin A to sustain high Smad2 levels, which otherwise drop dramatically in the absence of activin A. This activin A-dependent Smad2 expression is abrogated by protein kinase A (PKA) inhibitors, suggesting a role for PKA in activin signaling. In the absence of activin A, strong PKA activators such as follicle-stimulating hormone (FSH) and 8-bromo-cyclic AMP fail to elicit Smad2 induction. However, FSH and 8-bromo-cyclic AMP boost activin A-dependent Smad2 up-regulation, giving rise to Smad2 levels similar to expression in vivo levels. Interestingly, the effect is specific for Smad2, since expression of the structurally and functionally closely related Smad3 remains entirely unaffected. Hence, activin A induces Smad2, but not Smad3, to high levels requiring PKA activation. Since Smad2 and Smad3 target distinct yet overlapping sets of TGF-beta/activin-responsive genes, the selective Smad2 induction by FSH/activin A could allow FSH to efficiently modulate the transcriptional readout of activin A signaling in avian granulosa cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665510     DOI: 10.1074/jbc.M212425200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity.

Authors:  Xuhao Ni; Jinhui Tao; Joseph Barbi; Qian Chen; Benjamin V Park; Zhiguang Li; Nailing Zhang; Andriana Lebid; Anjali Ramaswamy; Ping Wei; Ying Zheng; Xuehong Zhang; Xingmei Wu; Paolo Vignali; Cui-Ping Yang; Huabin Li; Drew Pardoll; Ling Lu; Duojia Pan; Fan Pan
Journal:  Cancer Discov       Date:  2018-06-15       Impact factor: 39.397

2.  Whole-transcriptome analysis of atrophic ovaries in broody chickens reveals regulatory pathways associated with proliferation and apoptosis.

Authors:  Lingbin Liu; Qihai Xiao; Elizabeth R Gilbert; Zhifu Cui; Xiaoling Zhao; Yan Wang; Huadong Yin; Diyan Li; Haihan Zhang; Qing Zhu
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

3.  ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma.

Authors:  Laura Asnaghi; David T White; Nolan Key; Joshua Choi; Alka Mahale; Hind Alkatan; Deepak P Edward; Sahar M Elkhamary; Saleh Al-Mesfer; Azza Maktabi; Christopher G Hurtado; Grace Y Lee; Angel M Carcaboso; Jeff S Mumm; Leen Abu Safieh; Charles G Eberhart
Journal:  Oncogene       Date:  2018-11-06       Impact factor: 9.867

4.  Integrated lncRNA and mRNA Transcriptome Analyses in the Ovary of Cynoglossus semilaevis Reveal Genes and Pathways Potentially Involved in Reproduction.

Authors:  Yani Dong; Likang Lyu; Daiqiang Zhang; Jing Li; Haishen Wen; Bao Shi
Journal:  Front Genet       Date:  2021-05-19       Impact factor: 4.599

5.  Cooperative Effects of FOXL2 with the Members of TGF-β Superfamily on FSH Receptor mRNA Expression and Granulosa Cell Proliferation from Hen Prehierarchical Follicles.

Authors:  Ning Qin; Xian-Cong Fan; Xiao-Xing Xu; Thobela Louis Tyasi; Shi-Jun Li; Ying-Ying Zhang; Man-Li Wei; Ri-Fu Xu
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

6.  STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling.

Authors:  G Wang; Y Yu; C Sun; T Liu; T Liang; L Zhan; X Lin; X-H Feng
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

7.  A paracrine activin A-mDia2 axis promotes squamous carcinogenesis via fibroblast reprogramming.

Authors:  Michael Cangkrama; Mateusz Wietecha; Nicolas Mathis; Rin Okumura; Luca Ferrarese; Dunja Al-Nuaimi; Maria Antsiferova; Reinhard Dummer; Metello Innocenti; Sabine Werner
Journal:  EMBO Mol Med       Date:  2020-03-09       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.